HELX vs. SPY
HELX (Franklin Genomic Advancements ETF) and SPY (State Street SPDR S&P 500 ETF) are both exchange-traded funds - HELX is a Health & Biotech Equities fund actively managed by Franklin Templeton, while SPY is a S&P 500 fund tracking the S&P 500 Index. HELX is actively managed, while SPY is passively managed. Over the past 5 years, HELX returned -3.93%/yr vs 13.91%/yr for SPY. A 0.64 correlation means they provide meaningful diversification when combined. HELX charges 0.50%/yr vs 0.09%/yr for SPY.
Performance
HELX vs. SPY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HELX achieves a -1.55% return, which is significantly lower than SPY's 11.33% return.
HELX
- 1D
- 3.11%
- 1M
- 5.81%
- YTD
- -1.55%
- 6M
- -4.90%
- 1Y
- 33.84%
- 3Y*
- 5.75%
- 5Y*
- -3.93%
- 10Y*
- —
SPY
- 1D
- 0.38%
- 1M
- 4.60%
- YTD
- 11.33%
- 6M
- 11.25%
- 1Y
- 28.50%
- 3Y*
- 22.58%
- 5Y*
- 13.91%
- 10Y*
- 15.48%
HELX vs. SPY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
HELX Franklin Genomic Advancements ETF | -1.55% | 26.34% | -5.32% | 1.14% | -37.89% | 9.80% | 85.05% |
SPY State Street SPDR S&P 500 ETF | 11.33% | 17.72% | 24.89% | 26.18% | -18.18% | 28.73% | 28.02% |
Correlation
The correlation between HELX and SPY is 0.56, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.56 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.64 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.67 |
Correlation (All Time) Calculated using the full available price history since Feb 28, 2020 | 0.64 |
The correlation between HELX and SPY shifts across timeframes, from 0.56 (1 year) to 0.67 (5 years), reflecting how their relationship changes across market environments.
HELX vs. SPY - Sectors Allocation Comparison
Sectors
HELX
SPY
Healthcare
Basic Materials
Technology
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Financial Services
-
Industrials
-
Real Estate
-
Utilities
-
Healthcare
HELX
SPY
Basic Materials
HELX
SPY
Technology
HELX
SPY
Communication Services
HELX
-
SPY
Consumer Cyclical
HELX
-
SPY
Consumer Defensive
HELX
-
SPY
Energy
HELX
-
SPY
Financial Services
HELX
-
SPY
Industrials
HELX
-
SPY
Real Estate
HELX
-
SPY
Utilities
HELX
-
SPY
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HELX vs. SPY — Risk / Return Rank
HELX
SPY
HELX vs. SPY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Franklin Genomic Advancements ETF (HELX) and State Street SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HELX | SPY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.81 | ||
| Sortino ratioReturn per unit of downside risk | -0.97 | ||
| Omega ratioGain probability vs. loss probability | 1.28 | 1.44 | -0.16 |
| Calmar ratioReturn relative to maximum drawdown | 1.89 | 3.22 | -1.33 |
| Martin ratioReturn relative to average drawdown | 4.88 | 14.99 | -10.11 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HELX | SPY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.61 | 2.42 | -0.81 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.16 | 0.82 | -0.98 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.87 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.25 | 0.59 | -0.34 |
Drawdowns
HELX vs. SPY - Drawdown Comparison
The maximum HELX drawdown since its inception was -58.75%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for HELX and SPY.
Loading charts...
Drawdown Indicators
| HELX | SPY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.75% | -55.19% | -3.56% |
Max Drawdown (1Y)Largest decline over 1 year | -18.01% | -8.88% | -9.13% |
Max Drawdown (3Y)Largest decline over 3 years | -29.48% | -18.76% | -10.72% |
Max Drawdown (5Y)Largest decline over 5 years | -58.75% | -24.50% | -34.25% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.72% | — |
Current DrawdownCurrent decline from peak | -38.22% | -0.33% | -37.89% |
Average DrawdownAverage peak-to-trough decline | -34.32% | -9.05% | -25.27% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.95% | 1.91% | +5.04% |
Volatility
HELX vs. SPY - Volatility Comparison
Franklin Genomic Advancements ETF (HELX) has a higher volatility of 7.45% compared to State Street SPDR S&P 500 ETF (SPY) at 2.79%. This indicates that HELX's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HELX | SPY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.45% | 2.79% | +4.66% |
Volatility (6M)Calculated over the trailing 6-month period | 16.47% | 8.91% | +7.56% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.07% | 11.82% | +9.25% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.15% | 17.05% | +7.10% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.41% | 17.93% | +9.48% |
HELX vs. SPY - Expense Ratio Comparison
HELX has a 0.50% expense ratio, which is higher than SPY's 0.09% expense ratio.
Dividends
HELX vs. SPY - Dividend Comparison
HELX's dividend yield for the trailing twelve months is around 0.40%, less than SPY's 0.98% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HELX Franklin Genomic Advancements ETF | 0.40% | 0.39% | 0.00% | 0.00% | 0.00% | 0.24% | 0.12% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY State Street SPDR S&P 500 ETF | 0.98% | 1.07% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% |
Frequently Asked Questions
HELX and SPY have a correlation of 0.56, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HELX has higher volatility (7.45%) compared to SPY (2.79%). In terms of maximum drawdown, HELX dropped -58.75% vs SPY's -55.19%.
On 5-year performance, SPY leads with 13.91% vs -3.93% for HELX. On fees, SPY is cheaper at 0.09% per year. On volatility, SPY has been the lower-risk option at 2.79%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, SPY has performed better with a 13.91% return vs -3.93%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SPY is cheaper with a 0.09% expense ratio, compared with 0.50% for HELX.
SPY has the higher dividend yield at 0.98%, compared with 0.40% for HELX.
HELX is categorized as Health & Biotech Equities, while SPY is S&P 500. They also come from different issuers: Franklin Templeton and State Street. Their fees differ too: 0.50% for HELX and 0.09% for SPY.
SPY currently has the higher Sharpe Ratio (2.42 vs 1.61), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HELX and SPY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer